Loading clinical trials...
Loading clinical trials...
Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG in Patients With Primary Immunodeficiency
Conditions
Interventions
IVIG
Start Date
April 1, 2024
Primary Completion Date
January 8, 2025
Completion Date
June 8, 2025
Last Updated
March 12, 2024
NCT05755035
NCT06955793
NCT06150833
NCT01218438
NCT01175213
NCT03677557
Lead Sponsor
Azidus Brasil
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions